Oncology & Hematology Case Study

1. BUSINESS OBJECTIVES

Our client was developing a new treatment for Hodgkin’s lymphoma. It was necessary to understand the treatment decision-making process and uncover the factors that drive treatment choice and trigger changes in first-line treatment. The client was also looking to identify the most compelling reasons/benefits best support the uptake of their product as a new first-line indication.

2. BAZIS AMERICAS SOLUTION

Our research team conducted face-to-face interviews with onco-hematologists. We conducted in-depth interviews with key opinion leaders to understand the overall opportunity and value proposition for their product as a new first-line indication for HL.

3. CLIENT IMPACT

Based on the findings, our client gained clarity on Hodgkin’s lymphoma treatment approaches, goals, unmet needs, and the value perceptions for current treatment options. Our solution helped find the best future positioning of their product as a HL treatment.